Invus Opportunities

Invus Opportunities is a sister fund to The Invus Group, an equity investment firm founded in 1985 with over $8 billion of evergreen capital. Invus Opportunities is focused on partnering with market-leading management teams and investors in private transactions globally. With a differentiated heritage and capital base, Invus Opportunities brings a complementary dimension to growing companies and investor groups seeking to create lasting value. Invus Opportunities both leads rounds of financing and co-invests in syndicated financings, and currently manages over $1.5 billion.

Invus Opportunities, established in 1985 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Biotechnology, Health Care, Manufacturing, Hospital, Financial Services, Venture Capital, Finance, Angel Investment, Medical Device, Life Science. The organization boasts a portfolio of 48 investments, with an average round size of $100.1M and 9 successful exits. Their recent investments include CardiAQ Valve Technologies, Advent Life Sciences, Versant Ventures, OrbiMed, AqueSys. The highest investment round they participated in was $550.4B. Among their most notable exits are CardiAQ Valve Technologies and Advent Life Sciences. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.